Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Symeres
Symeres, previously known as Mercachem and Syncom, is a leading mid-sized European contract research organization (CRO) for integrated outsourced drug discovery services. Symeres focuses on serving smaller and midsized players with the quality and professional standards of larger CROs, enabling
Private Equity
Chr. Diener / Koscher & Würtz
Chr. Diener and Koscher & Würtz form a leading group of specialized contract manufacturers, focused on designing and producing precision reuseable and disposable surgical instruments. The group employs approximately 300 highly skilled workers across three production locations in the Tuttlingen
Private Equity
Stepp Footcare
Stepp Footcare is an integrated footcare provider specializing in podiatry and orthopedic services for patients across the Netherlands. The group provides light-touch care to complex footcare solutions through podiatry, orthopedics, and multidisciplinary treatments. The business adopts a unique approach known
